SCHEMBL24672322

SCHEMBL24672322

CC#C[C@@]1(O)[C@@H](COC(=O)c2ccccc2)O[C@H](O)[C@@H]1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
LMNA P02545 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNA5 P30532 1/20 0.38
CHRNA7 P36544 1/20 0.38
CHRNA4 P43681 1/20 0.38
NPC1 O15118 1/20 0.38
MAPK1 P28482 2/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 2/20 0.37
TSHR P16473 1/20 0.37
PPM1B O75688 1/20 0.37
NT5E P21589 1/20 0.36
HIF1A Q16665 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KMT2A Q03164 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7161198 0.87 ALDH1A1 (0.42) ALDH1A1LMNACHRNB2CHRNA5CHRNA7
SCHEMBL24672804 0.85 ALDH1A1 (0.44) ALDH1A1LMNACHRNB2CHRNA5CHRNA7
SCHEMBL27195180 0.85 ALDH1A1 (0.44) ALDH1A1LMNACHRNB2CHRNA5CHRNA7
SCHEMBL24672824 0.85 ALDH1A1 (0.44) ALDH1A1LMNACHRNB2CHRNA5CHRNA7
SCHEMBL16576322 0.81 ALDH1A1 (0.52) ALDH1A1LMNACHRNB2CHRNA5CHRNA7
SCHEMBL20557343 0.81 ALDH1A1 (0.52) ALDH1A1LMNACHRNB2CHRNA5CHRNA7
SCHEMBL17976785 0.81 ALDH1A1 (0.52) ALDH1A1LMNACHRNB2CHRNA5CHRNA7
SCHEMBL20733585 0.81 ALDH1A1 (0.52) ALDH1A1LMNACHRNB2CHRNA5CHRNA7
SCHEMBL7157387 0.81 ALDH1A1 (0.54) ALDH1A1LMNACHRNB2CHRNA5CHRNA7
SCHEMBL24672321 0.80 ALDH1A1 (0.40) ALDH1A1LMNACHRNB2CHRNA5CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368204-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2024-11-07 US disclosed
EP-4353732-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-04-17 EP disclosed
CN-117642411-A Small molecule CD73 antagonists and uses thereof 西藏海思科制药有限公司 2024-03-01 CN disclosed
WO-2022237747-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF 四川海思科制药有限公司 2022-11-17 WO disclosed
WO-2022237747-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF 四川海思科制药有限公司 2022-11-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240368204-A1 SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF ENTPD5, ENTPD1, ENTPD2 ALDH1A1 507/4885LMNA 2664/4885CHRNB2 777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.